4DXS
 
 | | Human SUN2-KASH2 complex | | Descriptor: | DECYL-BETA-D-MALTOPYRANOSIDE, Nesprin-2, POTASSIUM ION, ... | | Authors: | Sosa, B, Schwartz, T.U. | | Deposit date: | 2012-02-28 | | Release date: | 2012-06-06 | | Last modified: | 2024-11-27 | | Method: | X-RAY DIFFRACTION (2.71 Å) | | Cite: | LINC Complexes Form by Binding of Three KASH Peptides to Domain Interfaces of Trimeric SUN Proteins.
Cell(Cambridge,Mass.), 149, 2012
|
|
4DXR
 | | Human SUN2-KASH1 complex | | Descriptor: | DECYL-BETA-D-MALTOPYRANOSIDE, Nesprin-1, POTASSIUM ION, ... | | Authors: | Sosa, B, Schwartz, T.U. | | Deposit date: | 2012-02-28 | | Release date: | 2012-06-06 | | Last modified: | 2024-11-27 | | Method: | X-RAY DIFFRACTION (2.32 Å) | | Cite: | LINC Complexes Form by Binding of Three KASH Peptides to Domain Interfaces of Trimeric SUN Proteins.
Cell(Cambridge,Mass.), 149, 2012
|
|
4DXT
 | | Human SUN2 (AA 522-717) | | Descriptor: | POTASSIUM ION, SUN domain-containing protein 2 | | Authors: | Sosa, B, Schwartz, T.U. | | Deposit date: | 2012-02-28 | | Release date: | 2012-06-06 | | Last modified: | 2024-11-06 | | Method: | X-RAY DIFFRACTION (2.22 Å) | | Cite: | LINC Complexes Form by Binding of Three KASH Peptides to Domain Interfaces of Trimeric SUN Proteins.
Cell(Cambridge,Mass.), 149, 2012
|
|
9CZD
 | | Crystal structure of integrin avb6 headpiece in complex with compound 30 | | Descriptor: | (2S)-{5-fluoro-2-[(2S)-oxan-2-yl]phenyl}{(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl}acetic acid, 17E6 Fab heavy chain, 17E6 Fab light chain, ... | | Authors: | Monroy, M.F, Qiao, Q, Lin, F.Y. | | Deposit date: | 2024-08-05 | | Release date: | 2024-11-13 | | Last modified: | 2024-11-27 | | Method: | X-RAY DIFFRACTION (2.23 Å) | | Cite: | The Discovery of MORF-627, a Highly Selective Conformationally-Biased Zwitterionic Integrin alpha v beta 6 Inhibitor for Fibrosis.
J.Med.Chem., 67, 2024
|
|
9CZF
 | | Crystal structure of integrin avb6 headpiece in complex with compound MORF-627 | | Descriptor: | (2S)-{5-fluoro-2-[(6S)-5-oxaspiro[2.5]octan-6-yl]phenyl}{(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl}acetic acid, 17E6 Fab heavy chain, 17E6 Fab light chain, ... | | Authors: | Monroy, M.F, Qiao, Q, Lin, F.Y. | | Deposit date: | 2024-08-05 | | Release date: | 2024-11-13 | | Last modified: | 2024-11-27 | | Method: | X-RAY DIFFRACTION (2.53 Å) | | Cite: | The Discovery of MORF-627, a Highly Selective Conformationally-Biased Zwitterionic Integrin alpha v beta 6 Inhibitor for Fibrosis.
J.Med.Chem., 67, 2024
|
|
9CZ7
 | | Crystal structure of integrin avb6 headpiece in complex with compound 12 | | Descriptor: | (2S)-phenyl{(3S)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl}acetic acid, 17E6 Fab heavy chain, 17E6 Fab light chain, ... | | Authors: | Monroy, M.F, Qiao, Q, Lin, F.Y. | | Deposit date: | 2024-08-04 | | Release date: | 2024-11-13 | | Last modified: | 2024-11-27 | | Method: | X-RAY DIFFRACTION (2.57 Å) | | Cite: | The Discovery of MORF-627, a Highly Selective Conformationally-Biased Zwitterionic Integrin alpha v beta 6 Inhibitor for Fibrosis.
J.Med.Chem., 67, 2024
|
|
9CZA
 | | Crystal structure of integrin avb6 headpiece in complex with compound 18 | | Descriptor: | (2S)-(2-cyclopropylphenyl){(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl}acetic acid, 17E6 Fab heavy chain, 17E6 Fab light chain, ... | | Authors: | Monroy, M.F, Qiao, Q, Lin, F.Y. | | Deposit date: | 2024-08-05 | | Release date: | 2024-11-13 | | Last modified: | 2024-11-27 | | Method: | X-RAY DIFFRACTION (2.49 Å) | | Cite: | The Discovery of MORF-627, a Highly Selective Conformationally-Biased Zwitterionic Integrin alpha v beta 6 Inhibitor for Fibrosis.
J.Med.Chem., 67, 2024
|
|
